Skip Nav Destination
Letter|
April 9, 2025
The Impact of CMV Reactivation on Mortality After Chimeric Antigen Receptor T-Cell Therapy
Clinical Trials & Observations
Eleftheria Kampouri
Lausanne University Hospital and University of Lausanne, Switzerland
https://orcid.org/0000-0001-8019-3073
Search for other works by this author on:
Patrick W Flaherty
Patrick W Flaherty
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Search for other works by this author on:
Terry L Stevens-Ayers
Terry L Stevens-Ayers
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Search for other works by this author on:
Jordan Gauthier
Jordan Gauthier
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Search for other works by this author on:
Mazyar Shadman
Mazyar Shadman
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Search for other works by this author on:
Wendy M Leisenring
Wendy M Leisenring
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Search for other works by this author on:
Joshua A. Hill
Joshua A. Hill
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Search for other works by this author on:
Blood Adv bloodadvances.2024015164.
Article history
Submitted:
December 10, 2024
Revision Received:
March 19, 2025
Accepted:
March 20, 2025
